Companies:
49,811
Total Market Cap:
139340364113728.12
Global Rank
#1677
Country Rank
#18
Market Cap
11.93 B
Price
150.1
Change (%)
0.48%
Volume
486,254
ICON Public Limited Company's latest marketcap:
11.93 B
As of 07/05/2025, ICON Public Limited Company's market capitalization has reached $11.93 B. According to our data, ICON Public Limited Company is the 1677th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.
| Market Cap | 11.93 B |
| Revenue (ttm) | 8.19 B |
| Net Income (ttm) | 758.19 M |
| Shares Out | 79.46 M |
| EPS (ttm) | 9.19 |
| Forward PE | 11.10 |
| Ex-Dividend Date | n/a |
| Earnings Date | 07/23/2025 |
Market Cap Chart
Data Updated: 07/05/2025
ICON Public Limited Company's yearly market capitalization.
ICON Public Limited Company has seen its market value grow from $317.5 M to $11.93 B since 2002, representing a total increase of 3,656.72% and an annual compound growth rate (CAGR) of 17.48%.
| Date | Market Cap | Change (%) | Global Rank |
|---|---|---|---|
| 07/05/2025 | $11.93 B | -31.11% | 1677 |
| 12/31/2024 | $17.31 B | -25.61% | 1067 |
| 12/29/2023 | $23.27 B | 46.86% | 770 |
| 12/30/2022 | $15.85 B | -36.65% | 1025 |
| 12/31/2021 | $25.01 B | 139.26% | 822 |
| 12/31/2020 | $10.46 B | 12.48% | 1564 |
| 12/31/2019 | $9.3 B | 33.02% | 1428 |
| 12/31/2018 | $6.99 B | 14.26% | 1552 |
| 12/29/2017 | $6.12 B | 47.97% | 1991 |
| 12/30/2016 | $4.13 B | -11.51% | 2240 |
Company Profile
About ICON Public Limited Company
ICON Public Limited Company is a leading clinical research organization providing outsourced development and commercialization services globally, with operations in Ireland, Europe, the United States, and other international markets.
Core Services
- Clinical Development: Comprehensive support from compound selection to Phase I-IV studies, including peri- and post-approval services.
- Data Solutions: Advanced analytics and site/patient access services.
- Trial Management & Consulting: End-to-end clinical trial management, consulting, and contract staffing.
- Commercial Services: Strategy, planning, trial design, execution, and post-market commercialization.
Specialized Offerings
- Laboratory Services: Bioanalytical, biomarker, vaccine, GMP, and central lab solutions.
- Innovative Trial Solutions: Adaptive trials, decentralized/hybrid trials, cardiac safety, and medical imaging.
- Real-World Intelligence: Data-driven insights for clinical and commercial decision-making.
Industries Served
ICON serves a diverse clientele, including:
- Pharmaceutical companies
- Biotechnology firms
- Medical device manufacturers
- Government and public health organizations
Founded: 1989 | Headquarters: Dublin, Ireland
Frequently Asked Questions
-
What is ICON Public Limited Company's (ICLR) current market cap?As of 07/05/2025, ICON Public Limited Company (including the parent company, if applicable) has an estimated market capitalization of $11.93 B USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.
-
Where does ICON Public Limited Company (ICLR) rank globally by market cap?ICON Public Limited Company global market capitalization ranking is approximately 1677 as of 07/05/2025. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.